A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.

Thank you for joining us today for the Dr. Reddy's earnings conference call covering the quarter and full year ended March 31, 2025. We appreciate your time and participation. Joining us today is the ...

FDA will implement a secure generative AI system across all centers by June 30, aiming to streamline internal reviews and ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

With growing uncertainty in the US, Chinese companies are swooping in to present themselves as stable, open partners to the ...

Q1 2025 Earnings Conference Call May 9, 2025 4:30 PM ET. Company Participants. Bernie Hertel - Head of Investor Relations Punit Dhillon - Presi ...

The following is a letter sent by MHCare to Christopher McPherson, Alberta’s deputy minister for Jobs, Economy and Trade. We are writing to you to provide clarity regarding recent public discussions ...

A Science-Backed Natural Formula Supporting Healthy Thyroid Function, Energy, and Metabolism in 2025”New York, May 08, 2025 ...

This week, underscoring a commitment to national security, the White House and the Food and Drug Administration (FDA) issued separate communications that aim to bolster domestic drug manufacturing ...

The globalization of clinical research provides great opportunities for significantly improving the efficiency of the drug development process. For pharmaceutical companies, the benefits of ...

In today’s modern world, pollution is a common thing, and it gives rise to some of the common respiratory illnesses. I ...

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 7, 2025. REUTERS/Brendan McDermid/File photo U.S. stocks rose on Thursday as investors cheered a new ...